mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy?
Nadia VazirpanahAndrea OttriaMaarten van der LindenCatharina G K WichersMark SchuivelingEllen van LochemAmanda Phipps-GreenTony MerrimanMaili ZimmermannMatthijs JansenTimothy R D J RadstakeJasper C A BroenPublished in: Annals of the rheumatic diseases (2019)
We propose mTOR inhibition as a novel therapeutic target of interest in gout treatment.